Acalabrutinib, a BTK inhibitor, has shown promising results in treating mantle cell lymphoma, with the FDA granting it ...

Acalabrutinib, a Bruton tyrosine kinase inhibitor, is currently approved under the brand name Calquence ® for MCL in patients who have received at least 1 prior therapy. It is also indicated for the ...

AstraZeneca’s supplemental New Drug Application (sNDA) for CALQUENCE® (acalabrutinib) has been accepted and granted Priority Review in the US for the treatment of adult patients with previously ...

On Thursday, the FDA accepted and granted Priority Review to AstraZeneca Plc’s (NASDAQ:AZN) supplemental marketing ...

US FDA accepts and grants priority review status to AstraZeneca’s sNDA for Calquence to treat patients with untreated MCL: Cambridge, UK Friday, October 4, 2024, 09:00 Hrs [IST] ...

AstraZeneca's supplemental New Drug Application for Calquence (acalabrutinib) has been granted Priority Review by the US FDA ...

As the hostilities in the wider Middle East escalate, 7 October 2024 marks one-year since the Hamas-Israel conflict began. Israel's response escalated into conflicts with other organisations, ...

Advarra, the market leader in regulatory review solutions and clinical research technology for sites, sponsors, and clinical ...

The prime ministers of Malaysia and Pakistan have agreed to increase bilateral trade and boost economic ties after talks in ...

Focus changed how many fans followed the NFL by providing grades and advanced statistics to help quantify how every player ...

US President Joe Biden says he would not support any Israeli strike on Iran's nuclear sites in response to its ballistic missile attack, urging Israel to act "proportionally".

A pickup truck fire sparked alarm among locals and tourists along the Karon beachfront yesterday, September 23. The blaze broke out around 12.10pm near the Thavorn Palm Beach Hotel. Firefighters from ...